Mutations in the Huntington locus (htt) have devastating consequences. Gain-of-poly-Q repeats in Htt protein causes Huntington's disease (HD), while htt À / À mutants display early embryonic lethality. Despite its importance, the function of Htt remains elusive. To address this, we compared more than 3700 compounds in three syngeneic mouse embryonic stem cell (mESC) lines: htt À / À , extended poly-Q (Htt-Q140/7), and wild-type mESCs (Htt-Q7/7) using untargeted metabolite profiling. While Htt-Q140/7 cells did not show major differences in cellular bioenergetics, we find extensive metabolic aberrations in htt À / À mESCs, including (i) complete failure of ATP production despite preservation of the mitochondrial membrane potential; (ii) near-maximal glycolysis, with little or no glycolytic reserve; (iii) marked ketogenesis; (iv) depletion of intracellular NTPs; (v) accelerated purine biosynthesis and salvage; and (vi) loss of mitochondrial structural integrity. Together, our findings reveal that Htt is necessary for mitochondrial structure and function from the earliest stages of embryogenesis, providing a molecular explanation for htt À / À early embryonic lethality.
Introduction
The Huntington locus (htt) in the mammalian genome encodes a large protein called Huntingtin (Htt). Htt protein is maternally expressed from the first cell stage in the fertilized egg and subsequently is ubiquitously found in all cells of the embryo and adult. Mutations affecting the locus have dramatic consequences in both mouse and humans. Homozygote htt À / À embryos undergo developmental arrest, fail to undergo proper gastrulation, lack a proper node, display a shortened primitive streak, and exhibit an impaired patterning of embryonic germ layersearly embryonic lethality occurs by e7.0-7.5 (Duyao et al., 1995; Woda et al., 2005) .
In contrast to the lethality of htt À / À embryos, mutation of a single htt allele that expands the poly-Q (CAG) repeat at the N-terminal domain of Htt protein results in the dominantly inherited Huntington's disease (HD) (Duyao et al., 1995; Jacobsen et al., 2011) . HD is a devastating neurodegenerative disease typified by a progressive movement disorder, cognitive decline, and psychological impairment due to the death of medium spiny neurons in the striatum (Reiner et al., 1988) , and other areas of the brain (Tabrizi et al., 2011) . Some aspects of the disease can be recapitulated in rodent models by genetically increasing the length of the poly-Q repeat. As a platform to investigate Htt loss-and gain-of-function effects in the same genetic background, experiments were performed in syngeneic knock-in mouse embryonic stem cells (mESC) containing one copy of a humanized exon 1 (with an extended polyglutamine tract and adjacent proline-rich region; Htt-Q140/Q7), as well as knockout (htt À / À ) (Zheng et al., 2012; Nasir et al., 1995) , in comparison with mESC expressing the mouse htt gene (Htt-Q7/7). Importantly, studies of htt À / À mESC afford an opportunity to assess Htt protein function because viability is maintained as pluripotent cells, despite the lethality that invariably ensues in htt À / À mice during embryogenesis.
The embryonic functions of the Htt protein remain essentially unknown. Notwithstanding, Htt has been implicated in diverse cell processes in multiple investigated cell types. These include, but are not limited to trafficking of growth factor complexes (del Toro Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology Liot et al., 2013) , transcriptional regulation of a large variety of genes (Cha, 2007; Seong et al., 2010; Zuccato et al., 2001) , mitotic spindle orientation (Godin et al., 2010) , cell adhesion (Lo Sardo et al., 2012) , endocytosis and vesicular transport (Metzler et al., 2001; Pardo et al., 2010; Qin et al., 2004; Smith et al., 2009) , neuronal survival and neurogenesis (Reiner et al., 1988 (Reiner et al., , 2003 White et al., 1997) . Additionally, Htt protein is present in mitochondria of rat (Gutekunst et al., 1998) , mouse, and human somatic cells (Choo et al., 2004) and therefore, may be important for mitochondrial activities. In human lymphoblasts, the ATP/ADP ratio, a key measure of cellular energy reserves has been correlated with the length of the poly-Q extension in Htt, even when this length is in the normal range (Seong et al., 2005) . This apparent correlation raises the possibility that energy metabolism modulation may be a normal cellular role of Htt, not just a function acquired by the extension of the poly-Q region. Although Htt plays a crucial role in both embryonic development and disease initiation, the precise molecular and cellular functions of Htt in early embryonic cells and in the brain remain unknown (Woda et al., 2005) . In particular, the connection between Htt and metabolism during early development is essentially unexplored to date.
In this study, we used global untargeted metabolite profiling to compare the small molecule metabolome (50-1000 Da) of mutant htt in mESC, both gain-and loss-of-function, in comparison with the metabolome of wild-type mESCs. Our findings demonstrate that htt mutation results in profound dysregulation of key metabolic pathways during pluripotency. These studies reveal that mouse htt À / À ESCs exhibit severe bioenergetic and metabolic defects, including an essentially complete failure of mitochondrial ATP generation, associated with defects in mitochondrial structure. Conversely, mutant mESCs with poly-Q (Q140/7) do not exhibit apparent mitochondrial structural defects, but do show metabolic alterations, including a higher respiratory capacity with wild-type levels of nucleotide mono-, di-and tri-phosphates. Our findings provide a molecular explanation for the early embryonic lethality phenotype of the htt À / À mouse, and reveal a previously unrecognized but essential role for Htt in supporting mitochondrial bioenergetics, metabolism and structural integrity during early embryogenesis.
Materials and methods

Cell culture
Htt À / À , Htt-Q7/7, and Htt-Q140/7 mES cells were provided by Dr. Scott Zeitlin (University of Virginia) and propagated on 0.1% gelatin-coated plates, under serum-and feeder-free culture conditions in medium containing a 1:1 mix of DMEM-F12 (Invitrogen Cat# 12634) and neurobasal medium (Invitrogen Cat# 21103), supplemented with N2 (Invitrogen Cat# 17502), B27 supplement without Vitamin A (Invitrogen Cat# 12587), 2 mM GlutaMAX (Invitrogen Cat# 35050), 25 μg/ml of BSA (Invitrogen Cat# 15260), 10 μg/ml insulin (Sigma-Aldrich Cat# I9278), 0.1 mM βmercaptoethanol (Invitrogen Cat# 21985), 10 ng/ml LIF (Millipore Cat# ESG1107), 0.5 μM PD0325901 (Axon Med Chem, Cat# Axon 1408) and 3 μM CHIR99021 (EMD Millipore, Cat# 361559). Cell culture medium was changed daily and the cells were passaged by trypsinization every 3 days.
Metabolite extraction for metabolomic analysis
Cells were grown in 6-well plates to 70% confluency. Culture medium and cells were collected separately for analysis by untargeted metabolite profiling. For media analysis, the medium was centrifuged at 1500 rpm for 10 min at 4 1C to remove dead cells and debris; supernatants were collected and frozen at À 80 1C until the day of analysis. For analysis, media metabolites were directly extracted in 1:200 vol:vol 70% acetonitrile and aqueous 0.2% ammonium hydroxide and 3 ml of this extract was subjected to untargeted metabolite profiling by LC/MS. For analysis of cellular metabolites, cells were quickly washed twice with icecold PBS, followed by metabolic quenching and metabolite extraction using À 70 1C 80:20 methanol:water (LC-MS grade methanol, Fisher Scientific). Cold-quenched cells were scrape-harvested using a teflon cell scraper and transferred with 80% cold MeOH to 2.0 ml Tissuelyzer tubes (Qiagen). The cell-MeOH mixtures were incubated on dry ice for 10 min then subjected to beadbeating for 45 sec using a Tissuelyser cell disrupter (Qiagen). Extracts were centrifuged for 5 min at 5000 rpm to pellet insoluble material and supernatants were tranfered to clean tubes. This extraction was repeated two additional times and all three supernatants were pooled, dried in a speed-vac (Savant) and stored at À 80 1C until analysis. For normalization of sample analyses, post-extracted cell pellets were solubilized in 200 ml 0.2 M aqueous NaOH at 95 1C for 20 min and the pellet protein was quantified using the BioRad DC assay. On the day of metabolite analysis, dried cell extracts were reconstituted in 70% acetonitrile with 0.2% ammonium hydroxide at a relative protein concentration of 8 mg/ml and 3 ml of this reconsitued extract was injected for LC/MS-based untargted metabolite profiling.
Untargeted metabolite profiling
Both cell and culture medium extracts were analyzed by LC/MS essentially as described previously (Chen et al., 2012) , using a platform comprised of an Agilent Model 1200 liquid chromatography system coupled to an Agilent Model 6230 time-of-flight MS analyzer. Metabolite separation was performed by using aqueous neutral phase gradient chromatography on a Diamond Hydride column (Microsolv) and mobile phases as follows: (A) 50% isopropanol, containing 0.025% acetic acid, and (B) 90% acetonitrile containing 5 mM ammonium acetate. Raw data were analyzed using Agilent MassHunter Qual software, and Mass Profiler Professional software. Briefly, Qual performs untargeted molecular feature extraction to generate compounds/metabolites based on the elution profile at identical mass and retention times within a specified mass accuracy (5 ppm). Aligned molecular features detected in all biological replicates from at least one cell group (i.e., htt À / À , Htt-Q140/7 mutant and Htt-Q7/7 wild-type) were directly applied for statistical analysis across treatment groups by Mass Profiler Professional. The Bonferroni family-wise-error-rate correction was applied for multiple testing correction of p-values (corrected for po 0.05).
Differentially expressed metabolite identification
Differentially expressed metabolites in htt mutant mESC, with fold-changes greater than 2.0 (p o0.05), compared to htt wildtype mESC, were searched against an in-house annotated METLIN Personal Metabolite Database (Agilent Technologies), based on accurate monoisotopic neutral masses (o5 ppm). A molecular formula generator (MFG) algorithm in MPP was used to generate and score empirical molecular formulae based on a weighted consideration of monoisotopic mass accuracy, isotope abundance ratios, and spacing between isotope peaks. A putative compound ID was tentatively assigned when METLIN and MFG scores concurred for a given candidate molecule. Tentatively assigned compound identities were assigned and verified based on a match of LC retention times and/or MS/MS fragmentation spectra to that of pure molecule standards in our progressively growing database.
Mitochondrial oxygen consumption and glycolysis-derived lactate flux Glycolysis and oxidative phosphorylation flux analysis was performed using kits from Seahorse Biosciences, in accord with the manufacturer's recommendations. For these assays, cells were seeded on XF96 cell culture microplates (Seahorse Biosciences Cat# 101085-004) and grown to 70% confluency prior to analysis. On the day of assay, culture media were changed to XF Assay medium (Seahorse Biosciences Cat# 102365-100), supplemented with 5 g/L of glucose, 2 mM glutamine, and 2 mM pyruvate for oxidative phosphorylation assay and supplemented with only 2 mM pyruvate for assay of glycolysis rates. Prior to assay, plates were transferred into a non-CO 2 incubator at 37 1C and kept for 1 h. To quantify oxidative phosphorylation rates, we first measured initial (basal) oxygen consumption rates, followed by a series of changes in oxygen consumption when cells were sequentially treated with 2.5 μM oligomycin, 0.75 μM FCCP, and finally a combination of 1 μM rotenone and 1 mM antimycin. Following each addition, oxygen levels in the culture medium were monitored at 20 s intervals and the overall oxygen consumption rate (OCR) was calculated. For the glycolysis stress test, after collecting baseline acidification rate (lactate release) data, cells were sequentially treated with 10 mM glucose, 1 mM oligomycin, and 100 mM 2-deoxy-glucose and evoked changes in acidification rate were quantified after each addition. For this purpose, changes in culture medium pH was monitored every 20 s and used to calculate the overall extracellular acidification rate (ECAR).
Measurement of mitochondrial abundance
Mitotracker Red dye (Invitrogen, Cat# M7512) was used for the measurement of mitochondrial abundance. Cells were trypsinized and 10 5 cells were treated with Mitotracker Red dye (50 nM) in the mESC medium at 37 1C for 30 min. After incubation, the cells were spun down, washed with medium, resuspended in PBS containing 0.5% bovine serum albumin and then analyzed for fluorescence by flow cytometry. Flow cytometry analysis was performed using a BD LSRII instrument at Rockefeller University Flow Cytometry core facility.
Western blot analysis
Whole cell lysate was harvested using trypsin/EDTA and lysed in RIPA buffer containing protease inhibitors (Roche, and PMSF (1 mM). Lysate was centrifuged at 413,000 g for 10 min at 4 1C. Protein concentrations of lysate were measured by Bradford assay (Bio-Rad) and 60 μg total protein was loaded. Westerns were performed using the Novex NuPage SDS-PAGE blot system. Blots were probed with anti-cytochrome c (Millipore, #MAB1800), anticytochrome b-c1 subunit RISP (Millipore, #ABC322), anti-VDAC (Millipore, #MABN504), or anti-actin (Cell Signaling, #3700).
Measurement of mitochondrial membrane potential
A mitoprobe JC-1 assay kit (Invitrogen, Cat# M34152) was used for the measurement of mitochondrial membrane potential according to manufacturer's instructions. Briefly, the cells were trypsinized, 10 5 cells were resuspended in mESC medium, treated with 2 μM JC-1 at 37 1C for 30 min, washed and resuspended for fluorescence analysis by flow cytometry. TMRE (Invitrogen T-699) and MitoTracker DeepRed (Invitrogen M22426) co-staining, cells were trypisinized, washed twice with growth medium and incubated in medium containing TMRE (200 nM) and/or MitoTracker DeepRed (200 nM) for 30 min at 37 1C for 30 min. After incubation, cells were washed twice with media, resuspended in PBS and analyzed using a BD FACSArray instrument.
Electron microscopy
Cells were seeded on 6-well plates and grown to 90% confluence. The plates were processed according to previously published protocols (Cohen-Gould, 2013 ) and imaged at the Weill Cornell Medical College EM core facility. Mitochondria were counted blind using 4 200 mitochondria from EM images. 'Good' mitochondria were regular in shape, had defined outer membrane and well-developed cristae. 'Poor' mitochondria were those determined to have an irregular shape, compromised outer membrane, abnormal cristae, and/or a 'vesicular' morphology.
Results
Comparative metabolite profiling of htt À / À and htt-Q140/7 in embryonic stem cells
To broadly discover metabolic consequences in both htt À / À and Htt-Q140/7 mutant mouse stem cells, we performed untargeted liquid chromatography/mass spectrometry (LC/MS)-based metabolite profiling and compared to findings with wild-type Htt-Q7/7 stem cells. This analysis contrasted metabolite profiles in three syngeneic cell lines that differ only with regard to their htt genotypes when cultured under pluripotency conditions (see Materials and methods section). Profiling data were acquired using aqueous neutral phase LC and both negative-ion and positive-ion MS detection for broad coverage of potential changes in hydrophilic metabolite levels that contribute to intermediary metabolism. Together, this metabolomic analysis surveyed 3758 molecular features of 50-1000 Da mass/charge (m/z), considering only molecules that were detected in all biological replicates from at least one genetic group. Each genetic group comprised 9-10 replicate mESC cultures ( Fig. S1 ). Notably, 1384 species were quantified as negative ions ( Fig. S1A ) and 2374 species were detected as positive ions (Fig. S2A ). Principal component analysis (PCA) and unsupervised hierarchical cluster analysis (HCA) revealed within-group clustering and between-group separation of metabolites in samples prepared from each of the three different cell lines (Figs. S1B and C and S2B and C). Considering the 1384 species observed as negative ions, levels of 60 metabolites in htt À / À and 164 species in Htt-Q140/7 were significantly altered when compared to Htt-Q7/7 (p o0.05 and fold-change Z2.0; Fig. S1D ). Among these, 30 differences from Htt-Q7/7, overlapped between both htt À / À and Htt-Q140/7 mutants ( Fig. S1D and Table S1 ). A significant and marked effect of htt mutants on metabolite expression levels was similarly observed with positive ion detection, where 62 species in htt À / À and 192 species in Htt-Q140/7 differed significantly from Htt-Q7/7 (p o0.05 and fold-changeZ2.0; Fig. S2D ). Together, these findings establish that both htt À / À and Htt-Q140 mutations profoundly perturb metabolism in pluripotent embryonic stem cells.
htt À / À mESCs display accelerated glycolysis and ketogenesis
Despite the relative inefficiency of aerobic glycolysis for ATP generation, as compared to ATP generation by mitochondrial respiration, aerobic glycolysis is the predominant bioenergetic phenotype for rapidly proliferating cells (e.g., cancer cells) and is also typical of pluripotent embryonic stem cells (Folmes et al., 2012) . A hallmark feature of aerobic glycolysis is increased glucose uptake and accelerated metabolism to pyruvate, followed by NADH-mediated reduction to lactate and extracellular export.
To assess whether htt mutations are associated with an altered rate of glycolysis, we compared relative levels of glucose, lactate, and pyruvate, both intracellularly and in 24 h cell culture medium. Interestingly, htt À / À mutants displayed significantly increased levels of lactate, both intracellularly and extracellularly, compared to Htt-Q7 and Htt-Q140 ( Fig. 1) . Conversely, lactate release into the cell culture medium was relatively diminished in Htt-Q140/7 mutant cells. In accord with a relatively accelerated rate of aerobic glycolysis in htt À / À cells, the observed increase in lactate release was associated with a reciprocal decrease in intracellular and culture medium pyruvate levels (Fig. 1) . Additionally, htt À / À cells exhibited a 15-20% decrease in intracellular glucose and increased glucose uptake from the culture medium, when compared with normal Htt-Q7/7 and mutant Htt-Q140/7 cells, consistent with enhanced glucose consumption for aerobic glycolysis (Fig. 1) . These findings demonstrate that htt À / À mutation in mESC is associated with a metabolic switch toward increased aerobic glycolysis.
Targeted metabolite profiling of data described in Figs. S1 and S2, confirmed by chromatographic retention time and MS/MS fragmentation of standards, provided for a broad assessment of the effects of htt mutations on metabolic pathway intermediates, including those of glycolysis and the Krebs cycle ( Fig. S3 ). Notably, whereas htt À / À mutants showed a significant decrease in levels of glycolytic hexose intermediates (glucose-6-phosphate and fructose 1,6-diphosphate), all glycolytic triose intermediates except pyruvate increased in abundance. This finding is consistent with accelerated use of glucose for glycolysis, resulting in build-up of triose intermediates, increased pyruvate reduction to lactate and efflux of lactate into the culture medium. Increased conversion of pyruvate to lactate, in lieu of reductive decarboxylation by pyruvate decarboxylase to acetyl CoA for subsequent entry into the Krebs cycle, is in accord with more than 50% decrease in acetyl CoA levels observed in htt À / À mESCs (Fig. S3B ). In contrast, acetyl CoA levels were increased by almost 2-fold in Htt-Q140/7 cells ( Fig. S3B ). It is notable that β-oxidation of lipids provides an additional source of acetyl CoA for entry into the Krebs cycle, beyond that provided by glycolysis. However, insufficient catabolic consumption of acetyl CoA by the Krebs cycle can promote acetyl CoA condensation reactions that result in accumulation of ketone body products, including acetoacetic acid and β-hydroxybutyric acid. We observed that htt À / À cells exhibit a significant accumulation of these ketone bodies intracellularly and release ketones and hydroxyacids into the cell culture medium (Fig. S4 ). It is notable that although Htt-Q140/7 mESC did not exhibit altered levels of nucleotide mono-, di-, and tri-phosphate levels relative to wildtype Htt-Q7/7 mESC, other metabolite levels were significantly alteredthis included changes in nucleotide bases, lipid profiles, carnitines, sulfur metabolites and some amino acids (Fig. S5 ). Taken together, these findings demonstrate that metabolism in both htt À / À and Htt-Q140/7 mESCs is profoundly aberrant; in the case of htt À / À mESC this perturbation is characterized by an increased rate of aerobic glycolysis and failure to efficiently oxidize acetyl CoA by the Krebs cycle.
htt À / À mESCs are depleted of intracellular nucleotide triphosphates
Our finding of a ketogenic metabolism in htt À / À mESCs suggests impaired NADH production for support of ATP generation by aerobic respiration in mitochondria. Since glycolysis is far less bio-energetically efficient than aerobic respiration (2 vs. 36 mols ATP/mole glucose generated), we wondered whether htt À /À mutation may be associated with a relative bioenergetic deficit, reflected in decreased ATP/AMP and ATP/ADP ratios. To test this possibility, untargeted negative ion profiling data were assessed for relative levels of adenine nucleotide tri-, di-, and mono-phosphates in htt À /À relative to Htt-Q7/7 and Htt-Q140/7 cells (Fig. 2) . Notably, htt À /À cells exhibited a 50% decrease in ATP levels, concomitant with 2-fold increases in both ADP and AMP levels, compared to both Htt-Q7/7 and Htt-Q140/7. This relative energetic collapse observed in htt À /À cells for adenine nucleotides extended to other nucleotides of the guanine, cytosine, thymidine, and uridine mono-, di-, and triphosphate series. Indeed, levels of GTP, CTP, TTP and UTP were all decreased significantly in htt À /À compared to Htt-Q7/7 cells, concomitant with reciprocal increases in cognate mono-and diphosphate levels (with the sole exception of GDP, which remained unchanged in htt À /À cells; Fig. 2 ). In sharp contrast to the profound nucleotide tri-phosphate deficit and monophosphate/diphosphate increases in htt À /À mESC, nucleotide levels in Htt-Q140/7 were indistinguishable from levels in Htt-Q7/7 cells. Dissipation of the cellular reservoir of ATP and other nucleotide triphosphates in htt À /À cells demonstrates that Htt protein activity is critical for the maintenance of high energy phospho-metabolites.
htt À / À mutation accelerates purine biosynthetic and salvage pathways Interestingly, examination of the 30 molecules that are differentially expressed between htt À / À and Htt-Q7/7 ( Fig. S1D and Table S1 ) led to the identification of several molecules that are uniquely expressed in htt À / À cells. One such unique molecule (RT ¼10.97 min, Mass ¼295.0618 Da) was observed to have a formula consistent with C 8 H 14 N 3 O 7 P and was molecularly identified as 5-aminoimidazole ribonucleotide (AIR, Fig. 3 ). AIR is a pivotal intermediate in purine nucleotide biosynthesis, which involves 10 enzymes for the ultimate conversion of phosphoribosyl pyrophosphate to the first purine metabolite, inosine monophosphate. Examination of the relative abundance of all other intermediates involved in this pathway revealed that in addition to AIR, levels of five other purine biosynthetic intermediates were also markedly increased in htt À /À vs. Htt-Q7/7 cells. Indeed, similar to AIR, three out of five intermediates were only detected in htt À /À cellsthese include phosphor-ribosyl-formyl-glycineamidine (FGAM), formamidoimidazole-4-carboxamide ribotide (FAICAR), and 5 0 -phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole (SAICAR). The two other differentially expressed purine pathway intermediates were 5-aminoimidazole-4-carboxamide ribotide (AICAR, increased 7.1-fold) and the final pathway product, inosine monophosphate (IMP, increased 3.3-fold). In addition to purine biosynthesis intermediates, all detected purine salvage pathway metabolites and products were significantly increased in htt À / À cells, except for ATP and GTP, which significantly decreased (Fig. 2) . Together, these results reveal a substantial acceleration of purine synthesis and turnover in htt À / À mESCs, suggesting the operation of a biochemical regulatory mechanism that increases purine biosynthesis, potentially as compensation for the relative paucity of ATP, GTP and other nucleotide triphosphates in htt À / À mESC.
Htt protein activity is necessary for mitochondrial ATP synthesis AMP-activated protein kinase (AMPK) serves as a master switch that regulates cellular bioenergetics, including an activation of glucose uptake and accelerated glycolysis (Yuan et al., 2013) . Since AMPK is allosterically activated in cells in response to an elevated ratio of AMP/ATP as well as by direct binding of the AMP analog AICAR (Merrill et al., 1997) , both of which were increased in htt À / À cells, we considered whether htt À / À cells favored glycolysis over mitochondrial respiration as an ATP source. To directly test this possibility, both mitochondrial and glycolysis respiration rates were measured in all three mESC lines using an extracellular flux analyzer. Results showed that htt À / À cells consume 70% less oxygen compared to wild-type Htt-Q7/7 cells. In contrast, Htt-Q140/7 mESC displayed a relative 50% increase in oxygen consumption. Because oxygen consumption by htt À / À mESC was not decreased by the selective mitochondrial ATP synthase inhibitor, oligomycin, it is apparent that htt À / À mESC mitochondria do not contribute to ATP synthesis. This is in contrast to a marked degree of oligomycin-inhibited mitochondrial ATP synthesis in both Htt-Q7/7 and Htt-Q140/7 mESC.
To investigate whether htt À / À impairs electron transfer through the mitochondrial respiratory complexes, we measured the maximal respiratory capacity of htt À / À mESC for support of Fig. 3 . There is a marked intracellular accumulation of metabolites of de novo purine biosynthesis and purine salvage pathways in htt À / À compared with Htt-Q7/7 wild-type and Htt-Q140/7 mutant mESCs. The colors of fonts denote metabolites in htt À / À mESC with abundances that are significantly increased (red), decreased (blue), unchanged (black) and undetected (gray), in comparison with Htt-Q7/7 mESC. For each observed change, the measured p-values and fold-changes are given. *Denotes a significant difference with p o 0.05. The nomenclature for labeling of metabolic enzymes (names given adjacent to pathway arrows) is from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway map. Abbreviations: PPAT, phosphoribosyl pyrophosphate amidotransferase; GART, phosphoribosylglycinamide formyltransferase; PFAS, phosphoribosylformylglycinamidine synthase; PAICS, phosphoribosylaminoimidazole carboxylase; ADSL, adenylosuccinate lyase; ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; GMPS, guanine monphosphate synthetase; GUK, guanylate kinase; NME, nucleoside diphosphate kinase; 5 0 -NT, 5 0 -nucleotidase; PNP, purine nucleoside phosphorylase; AMPD, adenosine monophosphate deaminase; AK1, adenylate kinase 1; NME7, NME/NM23 family member 7. (For interpretation of the references to color in this figure caption, the reader is referred to the web version of this paper.) oxidative phosphorylation. Toward this end, we studied the effect of the mitochondrial uncoupling agent, carbonylcyanide-4-(trifluorometoxy)-phenylhydrazine (FCCP), on cellular oxygen consumption. Treatment of htt À / À cells with FCCP elicited a very modest increase in oxygen consumption, indicative of a minimal mitochondrial respiratory capacity (Fig. 4) . In contrast, Htt-Q140/7 mESC exhibited an apparently accelerated rate of mitochondrial ATP synthesis, compared to Q7/7 mESC, and additionally exhibited a greater mitochondrial respiratory reserve (Fig. 4A) . Together, these results suggest htt gene expression is essential for mitochondrial ATP synthesis and respiratory chain function and Htt mutations can alter mitochondrial bioenergetic capacities.
To test if htt À / À cells alter their rate of glycolysis-derived ATP in compensation for an apparent lack of mitochondrial ATP generation, extracellular acidification rate (ECAR) was quantified to assess glycolytic flux. After equilibrating mESC cell lines with glucose-free culture medium, 10 mM glucose was added to activate glycolysis and ECAR was quantified. While the glycolytic rate of Htt-Q7/7 and Htt-Q140/7 mESCs was essentially indistinguishable, htt À À/ À cells displayed an E2-fold greater rate of glycolysis (Fig. 4B ). Upon inhibition of oxidative phosphorylation with oligomycin, mESC lines responded with the anticipated increase in glycolysis, offsetting the elicited inhibition of mitochondria-derived ATP generation and revealing the cells maximal capacity for glycolysis. Whereas ECAR measurements demonstrated large and essentially identical glycolytic reserve capacities for both Htt-Q7/7 and Htt-Q140/7, htt À / À mESCs exhibited no detectable glycolysis reserve capacity whatsoever (i.e., cells were already operating at a maximum glycolytic rate prior to oligomycin treatment). A final addition of 2-deoxy-glucose to all cell lines resulted in a rapid and near-complete decrease in ECAR, confirming that the measurements were indeed due to glycolysis-derived lactate release. Taken together, these studies indicate that htt À / À mESCs are incapable of mitochondrial ATP synthesis and instead continuously generate ATP at near maximal capacity by glycolysis, without any apparent functional reserve.
Electron microscopy shows severe structural problems in htt À / À mitochondria Studies were performed in order to determine whether the failure of mitochondrial production of ATP in htt À / À mESCs is associated with conspicuous alterations in mitochondrial abundance, structural integrity, or functional capacity. In one line of investigation, electron microscopy (EM) was employed to compare structural features of mitochondria in the three mESC lines. Interestingly, EM images revealed that many mitochondria in htt À / À mESC are structurally abnormal exhibiting a relative paucity of cristae compared to Htt-Q7/7 and Htt-Q140/7 lines ( Fig. 5A-G) . Additionally, mitochondria in htt À / À mESC exhibited fragmentation, suggestive of initial stages of autophagy (as indicated by the loss of inner membrane structure) (Kubli and Gustafsson, 2012) (Fig. 5B) . These findings reveal that mitochondria are structurally aberrant in the absence of Htt protein.
We next assessed whether relative mitochondrial abundances differed in htt À / À , Htt-Q140/7, and Htt-Q7/7 mESC. Toward this end, mitochondrial abundance was compared on a per cell basis using FACS analysis, based on the mitotracker dye. Results demonstrated similar average fluorescence levels in all three cell lines (Fig. 5H) , indicating similar mitochondrial abundances and that loss of mitochondria from htt À / À mESCs does not explain their relatively low levels of total ATP and the apparent inability of mitochondria from these cells to produce ATP. We next took whole cell lysate from all three lines and probed for relative expression levels of the mitochondria specific proteins VDAC1, RISP (cytochrome b-c1 subunit 5), and cytochrome c. Results demonstrated that levels of these proteins across all three lines were indistinguishable ( Fig. 5I) .
Based on the mitochondrial structure perturbation in htt À / À cells, we next investigated the functional capacity of htt À / À cells to maintain their normal membrane potential. Toward this end, we used the fluorescent dyes JC-1 and TMRE as relative indicators of inner mitochondrial membrane potential. The greater the membrane potential the more the JC-1 and TMRE aggregation within mitochondria, and this is revealed by distinct fluorescence emission signals. In JC-1 experiments, a mitochondrial uncoupling agent (CCCP) was used as a control, for quantification of fluorescence emission upon complete dissipation of the electrical potential across the mitochondrial inner membrane. As expected, treatment of cells with CCCP resulted in a complete loss of the JC-1 aggregate fluorescence signal (Fig. 5J ). In TMRE experiments (Fig. 5K) , we additionally utilized the mitotracker dye to measure the abundance of mitochondria in relation to their membrane potential (Fig. 5L) . Surprisingly, results of these studies revealed that the mitochondrial membrane potential was completely preserved in htt À / À cells, despite their apparently complete loss of ATP-generating capacity (Fig. 4A) , and conspicuous structural deficits (Fig. 5B) . In fact, the mitochondrial membrane potential was similar in all three lines (Fig. 5J-L) . Paradoxically, we noted Fig. 4 . Influence of htt À / À and Htt-Q140/7 mutations on mitochondrial and glycolytic fluxes in mESCs. (A) Mitochondrial ATP synthesis rate, based on the oligomycin-inhibited oxygen consumption rate (OCR). At the indicated time, oligomycin was added to reveal the extent to which oxygen is being consumed for ATP synthesis. FCCP, an uncoupler of mitochondrial respiration was subsequently added to define the maximal capacity of cells for mitochondrial respiration. Finally, the combination of rotenone and antimycin was added to elucidate total mitochondrial oxygen consumption. Results demonstrated that ATP synthesis and synthetic capacity are dramatically impaired in htt À / À mESC, while ATP production rate and capacity are relatively increased in Htt-Q140/7 cells. (B) Glycolysis rate, based on the glucose-dependent extracellular acidification rate (ECAR). Initially, cells are in the glucose-free medium, followed by the addition of glucose at the indicated time. Oligomycin is subsequently added to block mitochondrial respiration and reveals the glycolytic reserve capacity (i.e., maximal rate of glycolysis). Finally, an inhibitor of glycolysis, 2-deoxyglucose (2-DG), is added to ascertain the extent to which OCR derives from glycolysis. These results demonstrate that htt À / À mESC conduct glycolysis at a near-maximal rate for energy production. In both panels, points depict mean values for eight replicate determinations ±SEM.
that the Htt À / À actually exhibits fewer depolarized mitochondria compared to either Htt-Q7/7 or Htt-Q140/7 (Fig. S6) . These results demonstrate that failure of ATP production in htt À À/ À cells is not associated with a diminished abundance or relative loss of inner mitochondrial membrane polarization, but is associated with a loss of structural integrity.
Discussion
The early embryonic lethality of htt À / À mice reveals an essential role for Htt in the mammalian development. However, despite decades of investigation focused on elucidating the basis for neurotoxicity of mutant Htt protein, the fundamental role of wild-type Htt remains unknown. In the present study we sought to define the broad impact of htt À / À and Htt-Q140/7 mutants on cell metabolism in pluripotent mESCs, a model of early development. Toward this end, we performed an untargeted metabolite profiling study in attempt to uncover differences in mESC in three syngeneic lines. Our findings demonstrate that extensive metabolic aberrations occur in both htt À / À and Htt-Q140/7, compared with Htt-Q7/7 mESCs. Most notable among these aberrations was a profound energy deficit in htt À / À cells, indicated by decreases in all nucleotide tri-phosphate (NTP) levels, along with reciprocal increases in nucleotide di-and monophosphate levels. In Htt-Q140/7 mESC, on the other hand, NTP levels were not markedly impacted although other energy metabolites are altered (Fig. S5) . This is consistent with the findings that patients with HD do not show a drastically altered ATP concentration (Arning et al., 2010) . It is thought that downstream modifiers influence the role mutant Htt plays in energy metabolism in the cell. Mitochondrial and glycolytic flux measurements in htt À / À mESCs showed that NTP deficits were in conjunction with an essentially complete failure of ATP production via oxidative phosphorylation and compensatory acceleration of glycolysisderived ATP production. Our findings strongly suggest that (I) Equivalent mitochondrial abundance is shown by western blot analysis of whole cell lysate of htt À / À , Htt-Q7/7, and Htt-Q140/7 for the mitochondrial protein VDAC1, cytochrome b-c1 subunit RISP, and cytochrome c. Equal amounts of protein were loaded and actin were used as controls. (J) Mitochondria from htt À / À mESC are polarized like mitochondria from Htt-Q7/7 and Htt-Q140/7 mESCs. FACS analysis assessed mitochondria potential after staining htt À / À , Htt-Q140/7 and Htt-Q7/7 mESCs with the mitochondrial voltage-sensitive fluorescent dye, JC-1. Negative control with the mitochondrial uncoupling agent CCCP depicts fluorescence spectral changes that occur when the mitochondrial potential was eliminated. Notably, JC-1 fluorescence results reveal polarization of mitochondria in all three htt lines. (K) Mitochondria from htt À / À mESC are polarized like mitochondria from Htt-Q7/7 and Htt-Q140/7 mESCs. FACS analysis assessed mitochondria potential after staining htt À / À , Htt-Q140/7 and Htt-Q7/7 mESCs with the mitochondrial voltage-sensitive fluorescent dye, TMRE. (L) The ratio of polarization to the number of mitochondria is roughly equivalent between htt À / À , Htt-Q7/7 and Htt-Q140/7. Intensity levels of TMRE were divided by the intensity levels of MitoTracker.
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glycolysis may operate at a maximal rate in htt À / À mESC, leaving no glycolytic reserve to accommodate increases in cellular energy demands. Electron microscopic analysis of htt À / À mESCs further revealed severe defects in mitochondrial structural integrity. Taken together, these findings demonstrate that Htt protein is necessary for both mitochondrial structure and function from the earliest stages of embryogenesis. It is notable that htt À / À embryos are smaller compared to their wild type littermates and die by E7.5 with increased apoptosis (Zeitlin et al., 1995) . Defects in both the transfer of nutrition from the visceral endoderm to the embryo (Dragatsis et al., 1998 ) and a general aberration in forming and patterning of the primitive streak have been suggested as the basis for embryonic death (Woda et al., 2005) . In view of the present metabolomic findings, we propose that disruption of oxidative phosphorylation is, in fact, the key driver of early developmental death of htt À / À embryos. Notably, htt À / À pluripotent mESCs are viable and exhibit a rate of proliferation that is indistinguishable from syngeneic wild-type Htt-Q7/7 cells. The viability of mESCs and pre-E7.5 embryos can be explained by the predominant bioenergetic reliance on glycolysis, allowing for survival despite the failed oxidative phosphorylation. With further cell development and differentiation beyond E7.5, however, mitochondrial-derived ATP becomes progressively greater (Chung et al., 2007; Vempati et al., 2008; Wilding et al., 2009; Baker and Ebert, 2013) , offering a likely explanation for the lethality phenotype of htt À / À mutant mouse.
In contrast to our finding that NTPs are preserved at their wild type levels in Htt-Q140/7 mESCs, a recent investigation of htt mutant mESCs observed a progressive decrease in ATP/ADP ratios with increasing poly-Q lengths (studied to a maximal length of Q111/7) (Jacobsen et al., 2011) . Moreover, this study did not observe the decrease in ATP/ADP that we found in htt À / À mESCs. A likely explanation for our seemingly discrepant findings regards culture conditions and cell growth details, including days in culture, cell density at harvest, frequency of media changes and culture media composition. Notably, the ability or inability of glycolysis alone to support all ATP needs of the cell will predictably be a function of whether the cells are expanding in rapid growth phase or quiescent, whether the media are relatively rich or poor, how frequently the cells are supplemented with fresh media and in what quantity. In this regard, we recognize that the above-mentioned study grew mESC in a serum-supplemented medium, while we cultured cells in a defined medium. One possibility is that undefined growth factors in serum compensate for the loss of mitochondrial ATP generation by htt À / À mESCs and thereby cloak the phenotype we observed herein. Clearly, direct metabolite profiling of htt À / À embryos will ultimately shed light to this apparent contrast between the two studies. Unfortunately, however, the number of mouse embryos required to perform such a study is prohibitive with current technologies. We are currently using CRISPR technology to generate htt À / À mutants in Xenopus taking advantage of the fact that early embryogenesis (from the fertilized egg onward) can be observed in a large number (hundreds) of embryos to overcome this limitation. Direct imaging and measurement of metabolomic profiles during very early stages of Xenopus embryonic development will inevitably provide further insights into the functions Htt in energy metabolism and in generation of respiration competent mitochondria, in vivo.
Surprisingly, and despite significant structural aberration, we observed no significant decrease in the abundance of mitochondria in htt À / À or Htt-Q140/7 mESCs. It is also remarkable that mitochondria from htt À / À mESC maintain their inner membrane potential despite their apparent inability to contribute to ATP generation. This unusual observation can be explained by one of the two scenarios that we model in Fig. 6 . In the first scenario, "normal" mitochondrial potential in htt À / À mESCs arises nonautonomously, at the expense of extra-mitochondrial ATP (Fig. 6A ). In this case, membrane potential might be maintained through reversed directionality of the mitochondrial ATP synthase complex (complex V in Fig. 6 ), a phenomenon previously reported to occur in some settings (Garedew et al., 2010) . Thus, glycolysis-derived ATP can be consumed for generation of a proton gradient (and ADP) in the inner mitochondrial membrane by a reversed directionality of the ATP synthase complexthis would establish a membrane potential and protect against cytotoxicity owing to mitochondria-dependent apoptosis. If operational, a reversal of ATP synthase directionality would require that glycolysis produces not only enough ATP to meet cellular demands for biochemical, mobility and transport processes, but would need to additionally provide ATP for preservation of the mitochondrial potential and hence, cell viability. Such a critical glycolytic demand for ATP would predictably cause cells to exist in a fragile state, susceptible to death by even modest transient increases in cell demands for ATP. In the second scenario, Htt may act in a mitochondria autonomous manner for coupling of the mitochondrial proton gradient to ATP generation (Fig. 6B ). If so, the absence of Htt would limit dissipation of the mitochondrial membrane potential and thereby promote the viability of cells despite an apparent failure in mitochondrial ATP synthesis. From the two scenarios we currently favor the first. This is due to our observation that tagged-Htt when Fig. 6 . Schematic depicting two alternative models that may explain the existence of a mitochondrial inner membrane potential in htt À / À mESC, despite a lack of mitochondrial ATP generation by these cells. The two models are distinguished as either arising via a mitochondria autonomous mechanism, wherein the respiratory complexes generate a proton gradient, but ATP synthase is unable to effectively use this proton gradient for ATP production (left panel), or arising via a mitochondria nonautonomous mechanism, wherein glycolysis-generated ATP serves to drive mitochondrial ATP synthase in reverse, resulting in a proton gradient at the expense of glycolysisderived ATP (right panel). Details of these models are considered in the text (adapted from Takeda et al., 2004) . overexpressed in human embryonic stem cells (hESCs) fails to localize to mitochondria, thus suggesting a non-autonomous effect (data not shown). Regardless of the mechanism however, this aspect of Htt function on mitochondria membrane potential was unexpected and previously unnoticed. The construction of syngeneic htt À / À , and gain-of poly-Q mutants, currently in progress in hESCs, and their comparison with wild-type cells, will allow performing the same analysis directly in humans. The comparison of the three human lines will identify metabolomic differences, and comparison of the human and mouse htt-mutants data sets will allow for a clear distinction between evolutionarily conserved and specie-specific differences between human and mouse.
We show that Htt-Q140/7 mutant that models HD do not display a defect in mitochondrial ATP synthesis in embryonic cells. In mature neurons, however, HD clearly leads to mitochondrial ATP deficit and cell death. Therefore, an interesting and unresolved question is: at what point of development does the initial damages from gain-of poly-Q mutation that ultimately leads to HD becomes cytotoxic? Providing the answer to this question at the cellular and embryological level will provide important clues on the progression of HD, and inevitably have a strong impact in the rationale design of HD treatments.
Finally, we note that mitochondrial biology is emerging as a key focus point in understanding the cellular and molecular basis of other neurodegenerative diseases. These include Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) (Martin, 2012; Federico et al., 2012) . In some instances, mitochondrial function is hampered due to aberrant protein-protein interactions that are disease specific. For example, amyloid precursor protein (APP) has only been observed associated with mitochondrial protein import channels TOMM40 and TIMM23 in AD brains, not in controls (Devi et al., 2006; Bettayeb et al., 2012) . This interaction blocks transfer of proteins into the mitochondria and perturbs energy metabolism (Bettayeb et al., 2012) . Similarly, certain mutants of SOD1 cause inherited ALS by associating with mitochondria and changing mitochondrial respiratory rate (Ferri et al., 2006; Faes and Callewaert, 2011) . Mitochondrial dysfunction can also be caused by the loss of normal protein function. For example, recessive mutations of PINK1, a mitochondrial kinase, have been shown to cause earlyonset PD (Hatano et al., 2004) . PINK1's interactions suggest that this is due to disruption of mitochondrial trafficking (Weihofen et al., 2009) . While the impact of a gain-of-poly-Q mutant Htt protein on mitochondria has been previously noticed in mature neuronal cells (Bossy-Wetzel et al., 2008; Browne, 2008) , we currently have a very little understanding of how the loss or impairment of normal Htt activity contributes to HD pathology (Mochel and Haller, 2011) . Our study demonstrates that Htt protein is necessary for the maintenance of mitochondrial structure and function, and thus links HD to a panel of neurodegenerative conditions that are either caused by or arise in conjunction with aberrant mitochondria. Understanding the molecular bases that connect Htt to mitochondrial function will provide novel insights into mitochondrial biogenesis and may translate into unanticipated strategies for therapeutic intervention in HD patients.
